Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,607,579
+$1,223,093 QoQ
Shares Held
75,252
+16.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#264
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EFG International AG holds $298,118,102 across 14 Drug Manufacturers - General names. NVO ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
374,628 | $95,144,269 | |
| 2 | LLY |
ELI LILLY & Co
|
75,750 | $90,856,826 | |
| 3 | AZN |
Astrazeneca PLC
|
343,663 | $65,165,375 | |
| 4 | ABBV |
AbbVie Inc.
|
71,881 | $18,088,131 | |
| 5 | MRK |
Merck & Co., Inc.
|
119,627 | $15,372,068 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
79,256 | $4,566,729 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
75,252 | $3,607,579 | |
| 8 | PFE |
Pfizer Inc
|
124,106 | $2,988,470 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,607,579 | 75,252 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,384,486 | 64,884 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,655,556 | 150,463 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||